SMTL ID : 6tel.2 (1 other biounit)

Crystal structure of Dot1L in complex with an inhibitor (compound 10).

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x N4Z: ~{N}1-[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]-~{N}2-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonyl-benzene-1,2-diamine(Non-covalent)

N4Z.1: 19 residues within 4Å: Chain A: E.130, P.131, F.132, S.141, L.144, V.145, M.148, V.170, F.240, V.241, N.242, F.244, A.245, V.268, S.269, S.270, V.311, S.312, Y.313 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.132, A:F.132, A:L.144, A:V.170, A:N.242, A:F.244, A:V.268 Hydrogen bonds: A:N.242, A:N.242, A:N.242, A:S.270 pi-Stacking: A:F.240, A:F.240, A:F.244

1 x K: POTASSIUM ION(Non-covalent)

K.2: 4 residues within 4Å: Chain A: K.53, L.54, M.56, N.58 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:K.53, A:M.56, H2O.4

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stauffer, F. et al., New Potent DOT1L Inhibitors forin VivoEvaluation in Mouse. Acs Med.Chem.Lett. (2019)

Release Date

2019-12-11

Peptides

Histone-lysine N-methyltransferase, H3 lysine-79 specific: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Histone-lysine N-methyltransferase, H3 lysine-79 specific

Related Entries With Identical Sequence